Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children

Clinica Chimica Acta

Volumn 276, Issue 2, 1998, Pages 121-127

  Čepelak, Ivana ^a   Žanić Grubišić, Tihana ^a   Mandušić, Anka ^b   Rekić, Branka ^c   Leniček, Jasna ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

^c INA Industrija Nafte d d   (Croatia)

^d Clinic for Children's Diseases   (Croatia)

Author keywords

Carbamazepine; Epileptic children; Liver enzymes; Valproic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; GAMMA GLUTAMYLTRANSFERASE; VALPROIC ACID;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; EPILEPSY; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ALANINE TRANSAMINASE; ANTICONVULSANTS; ASPARTATE AMINOTRANSFERASES; CARBAMAZEPINE; CATALYSIS; CHILD; DRUG THERAPY, COMBINATION; EPILEPSY; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; VALPROIC ACID;

EID: 0031716927     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00094-1     Document Type: Article

References (16)

1. McNamara JO. Drugs effective in the therapy of epilepsy. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, 1996:461-86.
2. Davis R, Peters DH, Burtis CA Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs. 47:1994;332-372.
3. Jeavons PM Non-dose-related side effects of valproate. Epilepsia. 25(Suppl 1):1984;S50-S55.
4. Tang W, Borel AG, Fujimiya T, Abbott FS Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. Chem Res Toxicol. 8(5):1995;671-682.
5. Braide SA, Davies TY Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anticonvulsant drugs. Ann Clin Biochem. 24:1987;391-399.
6. Battino D, Estienne M, Avanzini G Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine, and felbamate. Clin Pharmacokinet. 29:1995;341-369.
7. Sampson EJ, Baird MA, Burtis CA, Smith EM, Witte DL, Bayse DD A coupled-enzyme equilibrium method for measuring urea in serum: optimisation and evaluation of AACC study group on urea candidate reference method. Clin Chem. 26:1980;816-826.
8. Armitage P. Statistical method in medical research. Oxford: Blackwell, 1971.
9. Okesina AB, Donaldson D, Lascelles PT Serum gamma glutamyltransferase activities in epileptic patients receiving carbamazepine. Ann Clin Biochem. 28:1991;307-308.
10. Callaghan N, Majeed T, O'Connell A, Oliveria DB A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients. Acta Neurol Scand. 89:1994;237-241.
11. Oxley J, Hedges A, Makki KA, Monks A, Richens A Lack of hepatic enzyme inducing effect of sodium valproate. Br J Clin Pharmacol. 8:1979;189-190.
12. De Wolff FA, Peters ACB, Van Kempen GMJ Valproate induces urinary D-glucaric acid excretion. Lancet. i:1981;843.
13. Rogiers V, Callaerts A, Vercruysse A, Akrawi M, Shephard E, Phillips I Effects of valproate on xenobiotic biotransformation in rat liver. In vivo and in vitro experiments. Pharm Weekbl-Sci Edn. 14:1992;127-131.
14. Pisani F Influence of co-medication on the metabolism of valproate. Pharm Weekbl-Sci Edn. 14:1992;108-113.
15. Haidukewych D, Yielinski JJ, Rodin EA Deviation and evaluation of an equation for prediction of free carbamazepine concentration in patients comedicated with valproic acid. Ther Drug Monit. 11:1989;528-532.
16. Grlack F, Efry D Why measure carbamazepine-10,11-epoxide in patients on combined carbamazepine and sodium valproate therapy. Ann Clin Biochem. 25:1988;208s-209s.